Mathias Møllebæk
Postdoc
Copenhagen Centre for Regulatory Science
Universitetsparken 2, 2100 København Ø, 10 Universitetsparken 2, Building: 10-2-267
Member of:
ORCID: 0000-0001-9960-9024
1 - 3 out of 3Page size: 10
- 2020
- Published
Preparation of Direct Healthcare Professional Communication: An Exploratory Study on the Experiences and Perceptions of European Pharmaceutical Companies and the EMA
Fanø, A. B., Møllebæk, Mathias & Kaae, Susanne, May 2020, In: Therapeutic Innovation & Regulatory Science. 54, 3, p. 631-639Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Media coverage of drug regulatory agencies' safety advisories: A case study of citalopram and denosumab
Fabbri, A., O'Keeffe, M., Moynihan, R., Møllebæk, Mathias, Mohammad, A., Bhasale, A., Puil, L. & Mintzes, B., 2020, In: British Journal of Clinical Pharmacology. 86, 7, p. 1416-1429Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Rhetoric and STS
Møllebæk, Mathias, 2020, Communicating about Risks and Safe Use of Medicines: Real Life and Applied Research. Bahri, P. (ed.). Springer, p. 267-284Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research
ID: 170489612
Most downloads
-
20
downloads
Regulating Patient Access to Therapeutics in Denmark: a Rhetorical Analysis of Welfare Imaginaries in Public Controversy
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
16
downloads
Are Drug Safety Advisories Compatible with Physicians’ Information Behavior? Semi-Structured Interviews with General Practitioners about Direct to Healthcare Professional Communication
Research output: Contribution to journal › Journal article › Research › peer-review
Published